Table 1 Distribution of baseline characteristics in the tumor group and in the non-tumor group
From: Clinical characteristic and pathogenesis of tumor-induced acute pancreatitis: a predictive model
Variables | Tumor N = 100 | Non-tumor N = 360 |  | P |
|---|---|---|---|---|
Age (years) | 56.67 ± 11.03 | 47.03 ± 15.32 | t = 7.036 | 0.000 |
Sex | ||||
Male | 65 (65.0%) | 237 (65.8%) | χ2 = 0.024 | 0.877 |
Female | 35 (35.0%) | 123 (34.2%) | ||
Smoking | ||||
No | 69 (69.0%) | 270 (75%) | χ2 = 1.453 | 0.228 |
Yes | 31 (31.0%) | 90 (25%) | ||
Alcohol consumption | ||||
No | 84 (84.0%) | 291 (80.8%) | χ2 = 0.521 | 0.470 |
Yes | 16 (16.0%) | 69 (19.2%) | ||
Diabetes mellites | ||||
No | 88 (88.0%) | 310 (86.1%) | χ2 = 0.311 | 0.577 |
Yes | 12 (12.0%) | 50 (13.9%) | ||
Cholelithiasis | ||||
No | 74 (74.0%) | 231 (64.2%) | χ2 = 3.387 | 0.066 |
Yes | 26 (26.0%) | 129 (35.8%) | ||
Recurrent attacks | ||||
No | 41 (41.0%) | 312 (86.7%) | χ2 = 91.432 | 0.000 |
Yes | 59 (59.0%) | 48 (13.3%) | ||
Pancreatic duct dilation | ||||
No | 31 (31.0%) | 316 (87.8%) | χ2 = 157.330 | 0.000 |
Yes | 66 (66.0%) | 30 (8.3%) | ||
Unknown | 3 (3.0%) | 14 (3.9%) | ||
Bile duct dilation | ||||
No | 36 (36.0%) | 320 (88.9%) | χ2 = 149.367 | 0.000 |
Yes | 62 (62.0%) | 26 (7.2%) | ||
Unknown | 2 (2.0%) | 14 (3.9%) | ||
Severity of pancreatitis | ||||
Mild | 90 (90.0%) | 208 (57.8%) | H = 35.626 | 0.000 |
Moderately severe | 9 (90.%) | 134 (37.2%) | ||
Severe | 1 (1.0%) | 18 (5.0%) | ||
White blood cells (× 109/L) | 6.00 (4.63 7.78) | 10.00 (6.95 14.30) | Z = 7.811 | 0.000 |
Hemoglobin (g/L) | 127.00 (118.00 137.85) | 131.00 (116.00 148.00) | Z = 2.082 | 0.037 |
Hematocrit value | 0.39 (0.36 0.42) | 0.40 (0.35 0.44) | Z = 1.634 | 0.102 |
Neutrophilic granulocyte percentage (%) | 67.7 (58.4 73.6) | 81.6 (69.9 88.3) | Z = 7.735 | 0.000 |
Albumin (g/L) | 39.7 (36.7 42.2) | 38.1 (33.4 41.7) | Z = 2.749 | 0.006 |
Alkaline phosphatase (U/L) | 132 (83 298) | 82 (64 126) | Z = 5.755 | 0.000 |
Direct bilirubin (μmol/L) | 8.7 (4.3 94.4) | 7.1 (4.4 16.0) | Z = 2.634 | 0.008 |
Indirect bilirubin (μmol/L) | 7.0 (4.2 15.6) | 7.4 (4.9 13.3) | Z = 0.403 | 0.687 |
Creatinine (μmol/L) | 64 (55 78) | 64 (52 80) | Z = 0.161 | 0.872 |
Amylase (U/L) | 145 (73 275) | 155 (75 475) | Z = 1.228 | 0.219 |
Lipase (U/L) | 303.0 (181.7 874.7) | 201.3 (80.9 624.5) | Z = 3.351 | 0.001 |
C-reactive protein (mg/L) | 5.39 (1.82 35.45) | 51.10 (9.76 159.35) | Z = 4.552 | 0.000 |
Serum glucose (mmol/L) | 5.95 (4.64 7.47) | 6.86 (5.20 9.32) | Z = 2.958 | 0.003 |
Serum calcium (mmol/L) | 2.29 (2.21 2.35) | 2.18 (2.06 2.29) | Z = 5.875 | 0.000 |
Triglyceride (mmol/L) | 1.31 (0.84 2.11) | 1.75 (0.94 4.40) | Z = 2.919 | 0.004 |
Time (day) | 19 (12 29) | 11 (8 18) | Z = 5.877 | 0.000 |
Cost (yuan) | 64,297.80 (21,911.23 108,028.30) | 23,454.58 (14,498.46 43,762.65) | Z = 6.209 | 0.000 |